Barrier Factors of Adherence to Dupilumab Self-Injection for Severe Allergic Disease: A Non-Interventional Open-Label Study.
Kei HosoyaTaro KomachiKatsunori MasakiIsao SuzakiHidehisa SaekiNaoko KandaMakoto NozakiYosuke KamideYoshinori MatsuwakiYoshiki KobayashiEriko OginoShin-Ichi OsadaNorihiro UsukuraToshikazu KurumagawaJunya NinomiaMikiya AsakoKeitaro NakamotoHidenori YokoiManabu OhyamaKeiji TaneseSho KanzakiKoichi FukunagaMotohiro EbisawaKimihiro OkuboPublished in: Patient preference and adherence (2023)
The pre-filled dupilumab pen was superior to the syringe in terms of usability, operability, ease of pushing the plunger, and satisfaction. Repetitive instructions are recommended for preventing poor adherence to dupilumab self-injection.
Keyphrases
- atopic dermatitis
- open label
- ultrasound guided
- clinical trial
- high frequency
- healthcare
- health information
- early onset
- randomized controlled trial
- glycemic control
- electronic health record
- squamous cell carcinoma
- skeletal muscle
- study protocol
- drug induced
- type diabetes
- radiation therapy
- adipose tissue
- rectal cancer
- metabolic syndrome
- social media